Affordable Access

deepdyve-link
Publisher Website

Second primary cutaneous melanoma in patients with advanced melanoma treated with anti-programmed-death-receptor-1 monoclonal antibodies.

Authors
  • Charvet, E1
  • Kramkimel, N2
  • Chaplain, L1, 3
  • Gantzer, A1
  • Kassem, O1
  • Longvert, C1, 3
  • Blom, A1, 3
  • Dupin, N2
  • Aractingi, S2
  • Hamon, M4
  • Zimmermann, U4
  • Emile, J-F3, 4
  • Sohier, P5
  • Sidibé, T6
  • Saiag, P1, 3
  • Funck-Brentano, E1, 3
  • 1 Departments of, Department of, General and Oncologic Dermatology, Ambroise-Paré Hospital, AP-HP, Boulogne-Billancourt, France. , (France)
  • 2 Departments of, Department of, Dermatology, Cochin Hospital, AP-HP, Paris, France. , (France)
  • 3 EA 4340 'Biomarkers and Clinical Trials in Cancerology and Hemato-oncology', UVSQ, Université Paris-Saclay, Boulogne-Billancourt, France. , (France)
  • 4 Department of, Pathology, Ambroise-Paré Hospital, AP-HP, Boulogne-Billancourt, France. , (France)
  • 5 Department of, Pathology, Cochin Hospital, AP-HP, Paris, France. , (France)
  • 6 Department of, Pharmacy, Ambroise-Paré Hospital, AP-HP, Boulogne-Billancourt, France. , (France)
Type
Published Article
Journal
British Journal of Dermatology
Publisher
Wiley (Blackwell Publishing)
Publication Date
Apr 01, 2021
Volume
184
Issue
4
Pages
746–748
Identifiers
DOI: 10.1111/bjd.19629
PMID: 33098566
Source
Medline
Language
English
License
Unknown
Report this publication

Statistics

Seen <100 times